Research Centre and Facilities:
The research wing comprises of dedicated workstations for CRCs with individual computers that have broadband internet connections, dedicated fax line, scanning and STD/ISD facilities. A conference/monitoring room will be used for all monitoring visits, review meetings, the Ethics Committee (EC) meetings. The conference room is air-conditioned and has a LED projector for giving presentations, with a broadband internet connection and an STD/ISD line.


The research wing is situated on the first floor of the complex with all the facilities available for conducting research as per ICH- GCP standards and Schedule-Y.
The research wing has a secure drug storage room with a locked door which has biometric fingerprint restricted access, 24-hour air – conditioning facility with temperature surveillance and individualized locked cupboards for storing Investigational Products (IP). The drug storage room also has a refrigerator, minus 20°C and minus 70°C deep freezer.
Prof(Dr.)L. Sreenivasa Murthy is Part of Landmark Trials like HOPE-3, Clarify, BEGIN-BOOST, Degludec, ELIXA, EFC etc
Whenever there is need to store IPs of two different trials ina single unit (Refrigerator/Deep freezer) necessary precautions will be taken to maintain the confidentiality of the IP’s and to avoid misuse, by compartmentalizing them with thermocol, which will be clearly labelled. All instrumentswill be calibrated twice a year and calibration certificates maintained in separate file in PI’s Chamber. The entire unit is backed by 24-hour on-line UPS & Back up Diesel Generator of capacity 63 kva .
The Lifecare hospital and Research Centre was inspected by US FDA in 2012 without major findings!
World’s first ever CANADIAN HEALTH AUTHORITY inspection (outside Canada) was conducted at LIfecare hospital in 2018.
we have faced DCGI inspection from Government of India and many sponsor audits!
Research & Clinical Trials
Sentinel surveillance study
Sitatliptin versus Glipizide
A randomised, multicentric, double blind,
Protocol Id: MK-0431-102-01
Protocol Id: MK0941-007 -03
Trial ID: NN5401-3593


Protocol ID: SYR-322MET_302 Study
Protocol Title: DUT-MD-303 Study
Protocol Title: DUT-MD-304 Study
Protocol ID: RIT-1/AID Study
Study ID:MK-0431-262
LANTU_C_02761:
LANTU_C_02761 EXT:
LANU_C_04589:
BI 1245.19:
BI1245.20:
MB102-055:
MB102-054:


CLCZ696:
BI1245.31:
MK0431-130:
MB102-073:
MB102077-A
Trial ID NN9068-3697 :
TRIAL ID: ELIXA- EFC11319:
TRIAL ID:NN5401-4149
TRIAL ID NN95353625 :
TRIAL ID : EFC12382:
TRIAL ID : DI680R00019:
Cme Titled ‘Sudden Cardiac Death’


Better Health Care is Our Mission
+918023631055
2748/2152, M.L.N Enclave,
16TH ‘E’ Cross Road,
8TH Main,’D’ Block
next to Corporation Bank,
Sahakara Nagar, Bangalore-560092